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Abstract 
Background: This service evaluation explores patient reported outcomes from patients provided 
with high definition ocular prostheses (artificial eyes). 
Methods: Validated patient questionnaires (FACE-Q, DAS24 and HADS) were utilised to 
evaluate patient experiences of their new ocular prosthesis. 10 patients were included in the 
service evaluation, which was conducted between December 2018 and September 2019. 
Descriptive analysis of the mean and 95% CI was undertaken for all questionnaires. Statistical 
analysis was performed using SPSS 21 Principal Component Analysis (PCA) for FACE-Q 
questionnaires. Correlations were significant when factor loading is at α > 0.4. 
Results: A questionnaire response rate of 80% was achieved (n=8). PCA analysis showed the 
number of variables tested could be reduced. Two principal components (PC1 and PC2) had 
very good to excellent internal consistency between variables with factor loading (α = 0.7-0.9). 
PC1 contained questionnaires 1-7, all of which were highly correlated. PC2 contained question 
number 8 with a factor loading of α = 0.8. This indicates good reliability, validity and 
responsiveness.  
Conclusion: We hope to demonstrate the importance of service evaluations with respect to 
rapidly evolving technological advances in medical devices, pharmaceuticals and imaging 
modalities. Further feasibility and full clinical studies are required to confirm the positive results 









Healthcare technology advances have reduced mortality and morbidity, increased longevity and 
improved quality of life for people worldwide. However, this has also resulted in ever increasing 
healthcare costs both as an absolute value and as a percentage of GDP since the inception of 
the National Health Service in the UK 1. Service evaluations are increasingly used to address 
key stakeholder requirements, informing funding provisions, and guide local and national 
service provision models. 
Within ophthalmology the landscape of service provision has greatly changed due to 
technological advances as seen by the setting up of intravitreal injection clinics, glaucoma 
monitoring units, and diabetic retinopathy screening services. This rapidly changing world of 
clinical practice due to technological advances has resulted in service evaluations becoming a 
vital part of the armemantarium in the clinical governance toolkit.  
Novel medical devices, imaging modalities and pharmaceuticals are rapidly expanding and 
accounting for ever increasing quality of healthcare delivery as well as percentage of healthcare 
budgets.  
Procurement justification for novel medical devices is becoming increasingly focused on value 
rather than price alone, which has made Patient Reported Outcome Measures (PROMs) more 
widely used in their evaluation 2. In the UK, 65% (121 out of 186) of novel medical device 
studies between 1998 and 2018 included PROMs 2. While in the US, there has been over a 
500% increase in the utilisation of PROMs in medical device trials between 2009 and 2015 3. 
The primary aim of this paper was to demonstrate the importance of service evaluations in the 
refinement of a new service. The example we provided is of novel artificial eye service, which 
can provide life-like artificial eyes within a short manufacturing timeframe. Our aim is to improve 
the initial rehabilitation pathway and long-term quality of life of artificial eye patients. Therefore, 
the outcome measures used are based on quality of life.  
Service evaluations and clinical audits are both placed in the sphere of clinical governance. 
Clinical audits tend to evaluate specific clinical outcomes of a service with a focus on clinical 
outcomes. Whilst service evaluations tend to have broader aims of addressing key stakeholder 




Patients may require surgery to remove a blind painful eye following trauma, cancers or 
congenital conditions. The operations carried out include eviscerations, enucleations and orbital 
exenterations. Following healing of the surgical area the subsequent rehabilitation involves 
fitting an artificial eye. Patients with ocular prostheses report a reduced quality of life and 
increased prevalence of depression and anxiety 4,5. In 2006, Song et al reported that patients 
who felt their artificial eye was imperceptible to others had higher patient satisfaction rates, 
irrespective of the surgery performed or implant provided 6. Despite this knowledge, there has 
been limited research into the scope for improvement in appearance of ocular prostheses. 
Following clinical observations and patient testimonials, there was clearly a high level of unmet 
patient need and demand for improvements in ocular prostheses within our local area. This 
stimulated the development of a novel technique for fabricating ocular prostheses by 
Maxillofacial prosthetists and medical illustrationists in Leeds Teaching Hospitals NHS Trust. 
This new manufacturing technique allows digital photography of the patient’s unaffected eye to 
produce high definition prostheses in a short time frame with increased patient personalisation 7. 
                                         
Our Service 
The production of our new technique began development within LTHT over 10 years ago, and 
has anecdotally been met with great praise from patients. All patients were originally recruited 
into the service following the provision of a National Artificial Eye Service (NAES) prosthesis. 
NAES are currently the national providers of ocular prostheses to National Health Service 
(NHS) users. Although there are over thirty other artificial eye service providers nationally, 
mainly within maxillofacial prosthetics laboratories. 
On referral to the LTHT service the maxillofacial prosthetist (PB) and medical photographers 
(TZ, TA) spend time with the patient designing their prosthesis and taking necessary digital 
photographs. Once fabricated, the prosthesis is fitted and minor adjustments made to suit 
patient’s preference if required 7. There is future scope for this process to be undertaken within 
one clinical session, however at present this is spread over the course of a week due to non-
clinical logistical pressures. Figure 1 demonstrates the current patient journey through this high 
definition ocular prosthetic service. 
         Figure 1 
 
The scope of this paper is to demonstrate formalised quality of life responses using validated 
questionnaires from patients utilising this new service. This information will support service 
improvement by identifying areas of potential development. 
 
Methods 
Our service evaluation was undertaken at Leeds Teaching Hospitals NHS Trust in Leeds Dental 
Institute. The Trust Research and Innovation Centre supported and approved the service 
evaluation. A sample size of ten adult patients (over 18 years old) was selected to capture a 
representative cross-section of services users on a convenience basis. This evaluation was 
performed over a nine month timescale (December 2018 to September 2019) and covered the 
complete patient pathway from initial visit, to manufacture of prosthesis, and finally patient 
questionnaires. A response rate of 80% (n=8) was achieved. 
Patients were evaluated via telephone conversations or letter responses, as per their personal 
preference. The majority (n=7) opted for telephone conversations considering their visual 
impairment, often affecting their remaining biological eye and causing difficulty in reading a 
written questionnaire with ease. The option for either phone or letter responses was highlighted 
as very important by patients during a previous Patient and Public Involvement (PPI) initiative 
regarding this new service. This PPI allowed patients the freedom to express their thoughts 
about the service directly to those involved in its development. 
Our choice of patient reported outcome measure (PROM) was based on literature review and 
online database searches; FACE-Q (FACE-Q © 2013), DAS24 (Derriford Appearance Scale 24) 
and HADS (Hospital Anxiety and Depression Scale) were selected 8-10. Literature review of 
PROMs specifically in relation to artificial eyes is scarce. However, there are many well 
validated PROMs for anxiety, depression, social interaction and appearance which can be 
applied to those who have lost an eye and require prosthetic replacement 10,11. In itself this 
creates a challenge in balancing between questionnaire validity and applicability. 
FACE-Q patient reported outcome instrument was assessed and eight individual questionnaires 
were selected based on clinical relevance: (1) Psychological function, (2) Satisfaction with eyes, 
(3) Adverse effects: Eyes, (4) Satisfaction with outcome, (5) Appearance-related psychological 
distress, (6) Social Function, (7) Satisfaction with facial appearance, (8) Expectations. 
Development of the FACE-Q instrument was well constructed resulting in reliable, valid and 
responsive measures 12-15. Participants would be asked to state how much they agree or 
disagree with statements such as “I feel positive about myself” and “I feel confident” in the 
Psychological Function questionnaire. Scoring system is standardised with a range of 1-4 and 
higher scores reflecting a better outcome. A Conversion Table transforms the raw scale 
summed score into an equivalent Rasch transformed score from 0 (worst) to 100 (best).  
DAS24 (Derriford Appearance Scale) is an instrument designed to measure adjustment to 
problems of visible difference and disfigurement 8. The initial open scoping questions are 
followed by those with psychometric scales for measuring distress and dysfunction. Participants 
are asked questions such as “How distressed do you get by shopping in department 
stores/supermarkets?” and “How distressed do you get when other people make remarks about 
your feature?”. The total score ranges from 11-96. Higher scores represent greater levels of 
social anxiety and social avoidance.  
HADS (Hospital Anxiety and Depression Scale) is a well-established validated scale with almost 
forty years of application to a broad variety of medical and surgical specialties 9. It was 
developed to evaluate patients with physical health problems. Being a relatively straightforward 
and quick scale to complete helps ensure maximal respondent attention. The fourteen items are 
divided evenly between anxiety and depression subgroups. Participants are asked to answer 
questions such as “I still enjoy the things I used to enjoy” and “I feel restless as if I have to be on 
the move”. Cumulative scores for each subgroup range from 0-21 and higher scores indicate 
greater levels of anxiety or depression. Scores of 0-7 are in the “normal” range; 8-10 suggests 
borderline abnormal levels of depression or anxiety; 11-21 is strongly suggestive of clinical 
depression or clinical anxiety.  
Although these measures were specifically designed for clinical trial evaluations with strong 
foundations in their development, the binary patient acceptability of the service was seen as a 
simple yet highly effective way to gauge patient preference and impact of the service. 
Descriptive analysis of the Mean and 95% Confidence Interval (CI) was undertaken for all 
questionnaires. Statistical analysis was performed using SPSS v.21 (SPSS Inc, Chicago, 
Illinois). Principal Component Analysis considered significant correlation at factor loading α > 
0.4. PCA was undertaken only on the comparable FACE-Q questionnaires due to the measures 





The FACE-Q instruments’ equivalent Rasch transformed score Means and 95% Confidence 
Intervals are discussed below and detailed in Table 1. 
The lowest scoring instrument suggesting highest levels of distress was for Adverse Effects: 
Eyes scoring at 36.6(CI:27.5,45.7) and asking whether participants were bothered by: “How 
your eyelid scars look?”, “Your eyes look hollowed out?”, and “Eye irritation?”. Appearance-
Related Psychological Distress instrument also scored low at 37.4(CI:13.1,61.7) and assessed 
areas such as “I feel stressed with how I look” and “I tend to avoid being around people”.  
The highest scoring instrument suggesting least distress was for Satisfaction with Outcome at 
63.7(CI:47.5,80.0) including questions such as: “I am pleased with the result” and “I am 
surprised at how good I look in the mirror”. Expectations questionnaire also scored high at 
61.8(CI:51.8,71.9) and covered areas such as “People will tell me how great I look” and “I will 
feel like I fit in.”  
A broad comparison to Klassen et al evaluation of FACE-Q questionnaires for patients 
undergoing cosmetic eye surgery is a good starting point, as there is currently no validated 
normative data for this qualitative tool with respect to artificial eye patients 15. The following 
instruments had similar scores. Psychological Function 54.7(CI:32.6,76.9) and Social Function 
54(CI:38.4,69.6) fell just below Klassen’s rounded up range of 60-90 for both questionnaires. 
While appearance related instruments of Satisfaction - Eyes 59(CI:38.7,79.3) and Satisfaction - 
Facial Appearance 53.6(CI:39.7,67.4) were within Klassen’s rounded up range of 50-80 and 50-
70, respectively.  




DAS24 Total Score Mean and 95% Confidence Interval is 41.7(CI:24.6,58.7). There was an 
outlier with a total score of 91/96, which may have impacted the overall result. The 95% CI is 
broad indicating requirement for a larger data set in future studies. McBain and colleagues 
report a mean of 37.5 in a similar patient population of artificial eye users 5. Questions 
contributing the most to the total score were “I am self-conscious of my feature”, “How confident 
do you feel”, and “How distressed do you get when other people make remarks about your 
feature?”.  




HADS Total Anxiety Score Mean and 95% Confidence Interval is 6.14(CI:2.5,9.7). According to 
the HADS classification of the total score the mean falls within the normal category (0-7). In a 
similar study population of artificial eye users, McBain et al report a slightly higher mean score 
at 6.9 in their study 5. In our study population the questions contributing the most to the anxiety 
total score were “I feel tense or wound up” and “I can sit at ease and feel relaxed”.   
HADS Total Depression Score Mean and 95% Confidence Interval is 6.28(CI:1.9,10.6). The 
HADS classification of the total score is the same as for anxiety scale. The mean falls within the 
normal category. McBain et al reported a higher mean score of 7.6 5. We found the questions 
contributing the most to the total score were “I still enjoy the things I used to enjoy” and “I feel as 
if I am slowed down”.  




Binary patient acceptability of the new service was 100% (8/8). 
Figure 2 
Principal Component Analysis 
PCA is an analytical statistical method of data reduction. As a dimension reduction tool it 
identifies the correlation between the variables (questionnaires) tested and assesses whether it 
is possible to reduce the number of variables while maintaining data variance. Correlations were 
significant when factor loading is at α > 0.4. The minimum number of variables is reached when 
their sum total accounts for ≥ 80% variance. 
PCA analysis showed two main components extracted accounted for 84% of the total variance. 
Thereby two dimensions in the component space account for 84% of the variance.  
The first seven questionnaires laid into one component (PC1) which accounted for 70% of the 
total data variance. The second component analysis (PC2) contained question number 8 
(FACE-Q Expectations) which accounted to 14% of the data variance. Therefore it was 
concluded that the number of variables can be reduced to 2 to include any of the variables in 
PC1 in addition to PC2. Table (1) shows the component matrix and the factor loading for each 
variable. PC1 contained questionnaires numbered (1-7) all of which were highly correlated with 
very good to excellent internal consistency with factor loading (α = 0.7-0.9). PC2 contained 
question number 8 with a factor loading of (α = 0.8). 




The evolution of orbital prostheses from the traditional hand-painted design has been explored 
by previous research teams 16,17, and usually published via single patient case reports. 
However, there is no evidence in the literature regarding the utilisation of digital photography 
and high-definition printing to identically replicate a patient’s unaffected eye. Our technique is 
currently used with patients who already have an ocular prosthesis, provided by a different 
service (NAES). 
Comparative bias may have arisen within patient responses, despite our efforts to minimise this 
by encouraging patients to evaluate the new prosthesis solely on its own merits. Future 
research should look at patient reported outcome measures for patients who have never had a 
prosthesis before. 
Reportable outcome measures from family, friends and clinicians of patients could prove useful. 
Family and friends have been shown to notice different aspects of the prostheses from our 
previous PPI experience. Some patients with an ocular prosthesis have poor visual function in 
their remaining eye, and therefore find it difficult to judge the appearance of a prosthesis. In 
these cases, those close to the patient are a valuable source of opinion. 
The sample size for this evaluation was limited. This number may have reduced the range of 
responses that could have been received, and so there is scope for missing patient opinions 
and the identification of potential strengths and weaknesses of the service. However, at this 
time the evaluation team felt the sample size would provide an indicative representation of the 
current service. We plan a larger scale review of the service at a later date. 
There is no specific patient reported outcome measure for use with patients who have an orbital 
prosthesis. We have therefore used a large number measures for a thorough preliminary 
service evaluation. However, patient fatigue and resultant degradation of data quality may occur 
when patients are required to complete excessive numbers of questionnaires. We have 
therefore used a statistical tool, Principle Component Analysis (PCA), in order to select a few 
high-yield questionnaires based on their data variance. Subsequent service evaluations that we 
will undertake will only use 2 out of the 8 FACE-Q questionnaires that we used for our initial 
evaluation. This should reduce patient fatigue, improve data quality and streamline the 
subsequent service evaluation. We would recommend PCA for refining service evaluations 
when there are no specific patient reported outcome measures. 
Service evaluations are within the remit of clinical governance and not research. As a result they 
can provide broad although still valuable results to guide service provision decisions. However, 
they are not designed to evaluate potential confounding features such as depression, anxiety 
and reason for surgery with respect to patient reported outcome measure results. A feasibility 
study followed by a full clinical trial, within the sphere of research, would be able to compare 
and contrast the traditional artificial eye to the new high-definition artificial eye. This step-wise 
approach would allow for evaluation of the patient reported outcomes in the feasibility study, as 
there no specific outcomes for artificial eyes. And thereby allow a better understanding, 
evaluation and minimisation of potential sources of bias in the full study. We plan to further 
evaluate the novel high-definition artificial eye with this approach.  
The results of this service evaluation will be disseminated to key stakeholders within the 
provision of orbital prosthesis within our region and also nationally, in the hope of making 
substantial changes and informing funding provisions 18. This aligns with the primary goal of 
evaluations in engaging stakeholders as active participants in the process and that the findings 
will be meaningful and useful to those ultimately responsible for assessing and improving the 
service. Regarding this service the key stakeholders involved are the participants (patients), 
active respondents such as local Eye Clinic Liaison Officers (ECLO) and Royal National Institute 
of Blind People (RNIB), consultants such as National Artificial Eye Service (NAES) and 
Specialist Commissioning Services Group representation, and the clinical team caring for the 




We hope to demonstrate the importance of service evaluations with respect to rapidly evolving 
technological advances in medical devices, pharmaceuticals and imaging modalities. 
Procurement justification for novel medical devices is becoming increasingly focused on value 
rather than price alone, which has made Patient Reported Outcome Measures (PROMs) more 
widely used in their evaluation. This is becoming especially important with increasing 
technological advances that need to be balanced against rising healthcare costs. Further 
feasibility and full clinical studies are required to confirm the positive results of the novel artificial 
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Table 1. FACE-Q: Descriptive Analysis of the Mean and 95% Confidence Interval. 
Table 2a-b. DAS24: Descriptive Analysis of the Mean and 95% Confidence Interval. 
Table 3a-d. HADS: Descriptive Analysis of the Mean and 95% Confidence Interval. 
Table 4. FACE-Q: Principal Component Analysis. 
Figure 1. Patient Pathway. Flowchart describing patient flow through the new ocular prosthesis 
service4. 
Figure 2. New Ocular Prostheses Appearance. Three cases demonstrating the new ocular 
prostheses with different iris colours provided by the service. The artificial eyes are as follows: 
top (patient’s left eye with brown iris), middle (patient’s right eye with green iris), bottom 






















Satisfaction Outcome 63.7(47.5,80.0) 
Satisfaction Appearance 53.6(39.7,67.4) 
Psychological 54.7(32.6,76.9) 
Adverse Eyes 36.6(27.5,45.7) 




DAS24 Total Score (a-x) 
Mean (95% CI) 41.7(24.6,58.7) 
 
DAS24 Individual Questions 



























HADS Total Anxiety Score 
Mean (95%CI) 6.14(2.5,9.7) 
  
HADS Individual Anxiety Questions 









HADS Total Depression Score 
Mean (95%CI) 6.28(1.9,10.6) 
  
HADS Individual Depression 
Questions 














PC1 PC2 PC3 PC4 PC5 PC6 
  
            
 (1)  Psychological 0.98* -0.05 -0.12 -0.03 0.03 0.06 
 (2)  Satisfaction_Eyes 0.96* 0.08 -0.05 0.17 0.10 0.07 
 (3) Adverse_Eyes -0.90* 0.27 0.20 0.16 -0.07 0.17 
 (4)  Satisfaction_Outcome 0.90* 0.22 0.25 0.15 0.22 -0.01 
(5) Appearance -0.87 0.25 0.30 0.23 0.09 -0.08 
(6) Social 0.84 0.27 -0.05 0.36 -0.26 -0.05 
(7) Statisfaction_Appearance 0.70 0.36 0.45 -.038 -0.11 -0.00 
(8) Expectations -0.28 0.85 -0.39 -0.13 0.06 -0.01 
Note. Extraction Method: Principal Component Analysis. 6 components were extracted. 
Rotation Method: Oblimin with Kaiser Normalisation. Significant correlations were accounted 
when factor loading (α > 0.4) 
*  Denotes excellent (≥0.9) internal consistency 
  


